{"id":11023,"date":"2018-07-25T08:44:19","date_gmt":"2018-07-25T12:44:19","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11023"},"modified":"2018-07-25T08:44:19","modified_gmt":"2018-07-25T12:44:19","slug":"congress-considers-340b-changes","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11023","title":{"rendered":"Congress considers 340B changes"},"content":{"rendered":"<p>(By Emily Rappleye for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>The House\u00a0<a href=\"https:\/\/energycommerce.house.gov\/hearings\/opportunities-to-improve-the-340b-drug-pricing-program\/\" target=\"_blank\" rel=\"noopener noreferrer\">reviewed<\/a>\u00a015 bills July 11 that would revamp the oversight, transparency and organization of the 340B Drug Discount Program.\u00a0 <a href=\"https:\/\/www.beckershospitalreview.com\/legal-regulatory-issues\/congress-considers-340b-changes.html\">Continue reading article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/10\/dreamstime_s_56546786-\u00a9-Alexander-Bakanov-Dreamstime_com_-700x445.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-8430\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/10\/dreamstime_s_56546786-\u00a9-Alexander-Bakanov-Dreamstime_com_-700x445-300x191.jpg\" alt=\"\" width=\"300\" height=\"191\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/10\/dreamstime_s_56546786-\u00a9-Alexander-Bakanov-Dreamstime_com_-700x445-300x191.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/10\/dreamstime_s_56546786-\u00a9-Alexander-Bakanov-Dreamstime_com_-700x445.jpg 700w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Emily Rappleye for Becker&#8217;s Hospital Review) The House\u00a0reviewed\u00a015 bills July 11 that would revamp the oversight, transparency and organization<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-11023","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11023"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11023\/revisions"}],"predecessor-version":[{"id":11024,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11023\/revisions\/11024"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}